References
- Mizuno K, Tsujino M, Takada M, Hayashi M, Atsumi K, Matsuda T. Studies on bredinin. I. Isolation, characterization and biological properties. J Antibiot (Tokyo) 1974;27:775–84.
- Ishikawa H. Mizolobine and mycophenolate mofetil. Curr Med Chem 1999;6:575–97.
- Gerber DA, Bonham CA, Thomson AW. Immunosuppressive agents: recent development in molecular action and chemical ap-plication. Transplant Proc 1998;1:89–90.
- Suthanthiran M, Morris RE, Strom TB. Immunosuppressants: cel-lular and molecular mechanisms of action. Am J Kidney Dis 1996;28:159–72.
- Hughes SE, Gruber SA. New immunosuppressive drugs in organ transplantation. J Clin Pharmacol 1996;36:1081–92.
- Kokado Y, Ishibashi I, Jiang H. Low dose cyclosporine, mizoribine and prednisolone in renal transplantation: a new triple therapy. Clin Transplant 1990;4:191–7.
- Inoue T, Kusaba R, Takahashi I, Sugumoto H, Kuzuhara K, Yamada Y, et al. Clinical trial of bredinine in renal transplantation. Transplant Proc 1981;13:315–8.
- Shiokawa Y, Akizuki R, Yokohari R, Hashimoto H, Kashiwazaki S, Kondo H, et al. Clinical evaluation of mizoribine on rheumatoid arthritis: a double-blind comparative study using lobenzariddiso-dium as a standard drug (in Japanese). Igakunoayumi 1991;156: 811–31.
- Yoshioka K, Ohashi Y, Sakai T, Ito H, Yoshikawa N, Nakamura H, et al. A multicenter trial of mizoribine compared with placebo in children with frequency relapsing nephritic syndrome. Kidney Int 2000;58:317–24.
- Kaneko K, Nagaoka R, Ohtomo Y, Yamashiro Y. Mizoribine for childhood IgA nephropathy. Nephron 1999;83:376–7.
- Aihara Y, Miyamae T, Ito S, Kobayashi S, Imagawa T, Mori M, et al. Mizoribine as an effective combined maintenance therapy with prednisolone in childhood-onset systemic lupus erythemato-sus. Pediatr Int 1999;19:2–11.
- Tanaka H, Suzuki K, Nakahata T, Tsugawa K, Ito E, Wada S. Mizoribine oral pulse therapy for patients with disease flare of lupus nephritis. Clin Nephrol 2003;60:390–4.
- Fukunishi T, Takahashi S, Hashinaka Y, Oota K, Nagano S, Takada K, et al. Bredinine concentration in blood and immunosup-pressive effect (in Japanese) Ishyoku Jpn J Transplant 1982;17 Supp1:750–2.
- Sonda K, Takahashi K, Tanabe K, Funchinose S, Hayasaka Y, Kawaguchi H, et al. Clinical pharmacokinetic study of mizoribine in renal transplantation patients. Transplant Proc 1996;28:3643–8.
- Kusaba R, Otubo 0, Inou T, Yujino M, Ishikawa H. Studies on pharmacokinetics of bredinin (in Japanese with an English ab-stract). Isyoku 1982:17 Supp1:585–93.
- Koshikawa S, Satou M, Narita K, Sakai N, Shiiya T, Koide T, et al. Clinical study of HE-69 (miziribine) on patients with incur-able nephritic syndrome - a multicenter open study (in Japanese). Kidney Dial 1987;23:971–80.
- Warabi H, Abe S, Kondo H, Ishikawa Y, Sugawara S, Shichikawa K, et al. Consecutive administration of mizoribine in rheumatoid arthritis: pharmacokinetic study (in Japanese with an English ab-stract). Ftheumatology 1991;5:287–300.
- Honma M, Yoichi I, Akizuki M, Kashiwazaki S, Kondo H, Hashi-moto H, et al. Late phase 2 study of U67, 590A pulse therapy for lupus nephritis: dose finding study (in Japanese). Kisotorinsyo 1993;27: 5191–225.
- Honma M, Akizuki R, Yokohari R, Hashimoto H, Kashiwazaki S, Kondo H, et al. Clinical evaluation of mizoribine on lupus nephri-tis: multicenter single-blind comparative study with inactive pla-cebo (in Japanese). Ftinsyo-Igaku 1989;5:795–824.
- Tanaka H, Suzuki K, Nakahata T, Sato T, Ito E. Mizoribine oral pulse therapy for a patient with severe lupus nephritis. Pediatr Int 2003;45:488–90.
- Tokuda M, Dobashi H, Hiraishi T, Mitsunaka H, Takahashi J, Hirohata M. Effect of mizoribine pulse therapy on the disease ac-tivity of rheumatoid arthritis refractory to the treatment with methotrexate. Ftheumatology 1998;20:525–6.
- Tanaka H, Tsugawa K, Nakahata T, Kudo M, Onuma S, Kimura S, et al. Mizoribine pulse therapy for a pediatric patient with steroid-resistant nephritic syndrome. Tohoku J Exp Med 2005;205:87–91.
- Kawasaki Y, Suzuki J, Takahashi A, Isome M, Nozawa R, Suzuki H. Mizoribine oral pulse therapy for steroid-dependent nephritic syndrome. Pediatr Nephrol 2005;20:96–8.
- Takei S. Mizoribine in the treatment of rheumatoid arthritis and juvenile idiopathic arthritis. Pediatr Int 2002;44:205–9.